Sei Kakinuma

Professor

Tokyo Medical and Dental University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Sei Kakinuma is a faculty member at Tokyo Medical and Dental University in Japan. His research areas include hepatic organoids, hepatology, and the molecular mechanisms of liver diseases, as highlighted by his recent publications. His work focuses on various aspects of liver function and pathology, including the role of immune responses in hepatitis and the effects of liver cell signaling pathways.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Collaborators (2)

Tomohiro Mizutani

Institute of Science Tokyo

JAPAN

View details

Yoshihito Kano

Tokyo Medical and Dental University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sei Kakinuma

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Crosstalk via ICAM-1 enhances supportive phenotype of stellate cells and drives hepatocyte proliferation in iPSC-derived hepatic organoids

Bile acid-FXR signaling facilitates the long-term maintenance of hepatic characteristics in human iPSC-derived organoids

Hepatitis B Virus-KMT2B Integration Drives Hepatic Oncogenic Processes in a Human Gene-edited Induced Pluripotent Stem Cells-derived Model

A20 in hepatic stellate cells suppresses chronic hepatitis by inhibiting DCLK1–JNK pathway‐dependent chemokines

Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors

Prognostic Significance of C-Reactive Protein in Unresectable Hepatocellular Carcinoma treated with Atezolizumab and Bevacizumab.

Suspension culture in a rotating bioreactor for efficient generation of human intestinal organoids.

Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR.

Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs.

Time course alterations of virus sequences and immunoglobulin titers in a chronic hepatitis E patient.

Collaborators (2)

Tomohiro Mizutani

Yoshihito Kano

Make your next move.